Toll Free Helpline (India): 1800 1234 070

Rest of World: +91-9810852116

Peer Reviewed Journal
Free Publication Certificate

Vol. 10, Issue 12 (2021)

Efficacy evaluation of different dosages of imidacloprid 600FS (Gaucho) against aphid in cumin (Cuminum cyminum L.) under field conditions

Author(s):
NK Meena, AK Verma, Ravi Y, Nanda Ram and BM Meena
Abstract:
Field trials were conducted at two locations, the Research Farm of ICAR-National Research Centre on Seed Spices, Ajmer and Budhwara, Pisangan (Ajmer) for two consecutive seasons, rabi 2016-17 and 2017-18, to evaluate the efficacy of different dosages of imidacloprid 600 FS (Gaucho) as seed treatments against aphids mixed population in cumin. A total of five treatments comprised of imidacloprid 600FS @ 3g a.i./kg seed, 3.6g a.i./kg seed and 4.2g a.i./kg seed, thiamethoxam 30FS @ 2.1g a.i./kg seed and untreated control. The trials result showed that all the treatments were found significantly superior over untreated control in management of aphid in cumin. Imidacloprid 600FS @ 4.2g a.i./kg seed, received zero aphid infestation up to 40 days after seed germination during both the years and locations and also exhibited statistically at par to imidacloprid 600 FS @ 3.6g a.i./kg seed with negligible population 0.04 aphids/plant at 40 days after seed germination in rabi 2016-17 in both the locations. Similarly, imidacloprid 600FS @ 4.2g a.i./kg seed had obtained the highest seed yield of cumin i.e. 1180, 1050 and 1305 and 1148 kg/ha at institute’s research farm and Budhwara in 2016-17 and 2017-18, respectively but statistically at par with imidacloprid 600 FS@ 3.6 g a.i./kg seed. Imidacloprid 600FS @ 4.2g a.i./kg seed did not recorded phytotoxic symptoms till 35 days after sowing.
Pages: 2474-2478  |  382 Views  167 Downloads


The Pharma Innovation Journal
How to cite this article:
NK Meena, AK Verma, Ravi Y, Nanda Ram, BM Meena. Efficacy evaluation of different dosages of imidacloprid 600FS (Gaucho) against aphid in cumin (Cuminum cyminum L.) under field conditions. Pharma Innovation 2021;10(12):2474-2478.

Call for book chapter